全球前列腺癌发病率与死亡率的最新格局
基于GLOBOCAN 2018数据及44国发病、76国死亡登记资料,分析全球前列腺癌年龄标化率与时间趋势。高收入国家发病率最高,加勒比与撒哈拉以南非洲死亡率最高;近5年多数国家发病率下降或稳定,死亡率以稳定为主。
要点
- 高收入地区发病率最高,南中亚与东亚最低
- 加勒比与撒哈拉以南非洲死亡率最高,亚洲最低
- 近5年多数国家发病率下降或稳定,死亡率多稳定
核心结论
- 全球多数国家前列腺癌发病率与死亡率近期呈下降或稳定趋势,高收入国家下降更明显。
研究设计与样本
- 基于GLOBOCAN数据库估计2018年各国及地区年龄标化发病与死亡率。
- 利用人群登记资料分析44国发病率与76国死亡率的趋势。
主要发现
- 发病率最高地区为澳大利亚/新西兰、北美、西欧与北欧及加勒比,最低为南中亚、北非及东南亚与东亚。
- 死亡率最高地区为加勒比(巴巴多斯、特立尼达和多巴哥、古巴)、撒哈拉以南非洲(南非)及前苏联部分地区(立陶宛、爱沙尼亚、拉脱维亚),最低为亚洲(泰国、土库曼斯坦)。
- 最近5年发病率在5国下降、35国稳定,东欧与亚洲4国继续上升。
- 最近5个数据年死亡率在3国上升、59国稳定、14国下降。
临床怎么用
- 解读各国前列腺癌发病与死亡趋势时需考虑PSA检测实践与治疗可及性差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Previous studies have reported significant variation in prostate cancer rates and trends mainly due to differences in detection practices, availability of treatment, and underlying genetic susceptibility. OBJECTIVE: To assess recent worldwide prostate cancer incidence, mortality rates, and trends using up-to-date incidence and mortality data. EVIDENCE ACQUISITION: We present estimated age-standardized prostate cancer incidence and mortality rates by country and world regions for 2018 based on the GLOBOCAN database. We also examined rates and temporal trends for incidence (44 countries) and mortality (76 countries) based on data series from population-based registries. EVIDENCE SYNTHESIS: The highest estimated incidence rates were found in Australia/New Zealand, Northern America, Western and Northern Europe, and the Caribbean, and the lowest rates were found in South-Central Asia, Northern Africa, and South-Eastern and Eastern Asia. The highest estimated mortality rates were found in the Caribbean (Barbados, Trinidad and Tobago, and Cuba), sub-Saharan Africa (South Africa), parts of former Soviet Union (Lithuania, Estonia, and Latvia), whereas the lowest rates were found in Asia (Thailand and Turkmenistan). Prostate cancer incidence rates during the most recent 5 yr declined (five countries) or stabilized (35 countries), after increasing for many years; in contrast, rates continued to increase for four countries in Eastern Europe and Asia. During the most recent 5 data years, mortality rates among the 76 countries examined increased (three countries), remained stable (59 countries), or decreased (14 countries). CONCLUSIONS: As evident from available data, prostate cancer incidence and mortality rates have been on the decline or have stabilized recently in many countries, with decreases more pronounced in high-income countries. These trends may reflect a decline in prostate-specific antigen testing (incidence) and improvements in treatment (mortality). PATIENT SUMMARY: We examined recent trends in prostate cancer incidence and mortality rates in 44 and 76 countries, respectively, and found that rates in most countries stabilized or decreased.
引用
- Culp MB, Soerjomataram I, Efstathiou JA, et al. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur Urol. 2019. PMID: 31493960. doi:10.1016/j.eururo.2019.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。